AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Isolagen, Inc., (ILE) has been granted E.U. patent EP0845963 entitled "The Use of Autologous Dermal Fibroblasts for the Repair of Skin and Soft Tissue Defects" covering the company's proprietary Isolagen Process in 17 European countries.
Frank DeLape, chairman of Isolagen, stated, "Securing this patent, which simultaneously covers 17 countries, is a critical step in protecting our intellectual property and growth opportunities in these additional E.U. member countries. It gives us the confidence in our technology platform as well as the proprietary protection to facilitate the build-out of the European marketplace."
The newly issued patent is effective in the following countries: ...
Source: HighBeam Research, E.U. patent covers autologous dermal fibroblasts for skin, soft...